Soluble CD40 in plasma and malignant pleural effusion with non-small cell lung cancer: A potential marker of prognosis
Objective: Soluble CD40 (sCD40) is a potential modulator for both antitumor responses and CD40-based immunotherapy; however the levels and significance of sCD40 in non-small cell lung cancer (NSCLC) patients with malignant pleural effusion are unknown. Methods: Forty-eight patients with lung cancer...
Guardado en:
Autores principales: | Chuan-Yong Mu, Pang-Xue Qin, Qiu-Xia Qu, Cheng Chen, Jian-An Huang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/329cb7b479a049c5a57f6d5c4e23ac55 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mutant KRAS promotes malignant pleural effusion formation
por: Theodora Agalioti, et al.
Publicado: (2017) -
The prevalence of tumour markers in malignant pleural effusions associated with primary pulmonary adenocarcinoma: a retrospective study
por: Katrine Fjaellegaard, et al.
Publicado: (2021) -
Single-cell analysis of diverse immune phenotypes in malignant pleural effusion
por: Zhong-Yin Huang, et al.
Publicado: (2021) -
The investigation of the volatile metabolites of lung cancer from the microenvironment of malignant pleural effusion
por: Ke-Cheng Chen, et al.
Publicado: (2021) -
Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection
por: Marazioti A, et al.
Publicado: (2019)